Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 16, 2023
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
Joseph Stringer Reiterated (CARA) at Strong Buy and Held Target at $22 on, May 16th, 2023
Joseph Stringer of Needham, Reiterated "Cara Therapeutics, Inc." (CARA) at Strong Buy and Held Target at $22 on, May 16th, 2023.
Joseph has made no other calls on CARA in the last 4 months.
There are 3 other peers that have a rating on CARA. Out of the 3 peers that are also analyzing CARA, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Joseph
- Daniel Wolle of "JP Morgan" Maintained at Buy with Decreased Target to $16 on, Tuesday, March 7th, 2023
- David Amsellem of "Piper Sandler" Maintained at Buy with Decreased Target to $13 on, Tuesday, March 7th, 2023
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023
